Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.061
Sell
RSI(14)
31.765
Neutral
STOCH(KDJ)(9,3,3)
18.235
Neutral
ATR(14)
0.126
Low Volatility
CCI(14)
-136.413
Sell
Williams %R
94.643
Oversold
TRIX(12,20)
-0.728
Sell
StochRSI(14)
0.000
Sell
Search
Cardio Diagnostics Holdings Inc
CDIOAdd to Watchlist
1.550USD
-0.050-3.13%
Close 07-24 16:00（ET）Quotes delayed by 15 min
4.59MMarket Cap
0.06P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-3.13%
5 Days
-9.88%
1 Month
-23.65%
6 Months
-20.10%
Year to Date
-42.80%
1 Year
-66.16%
Key Figures
1.630Open
1.645High
1.24MVolume
0.06P/E TTM
--P/E Dynamic
--Dividend TTM
41.83%Turnover Ratio
1.630Prev. Close
1.520Low
1.08MTurnover
LossP/E Static
0.52P/B
0.00%Div Yield TTM
-60.90%ROA
7.91052wk High
4.63Volume Ratio
-8.38MNet Profit
2.96MShares
24.7603EPS TTM
2.20Beta
-65.59%ROE
0.97052wk Low
7.67%Amplitude
100.00%Gross Margin
4.59MMarket Cap
-2.17Reward/Risk
8.73%Risk Rate
TradingKey Stock Score of Cardio Diagnostics Holdings Inc
Currency: USD Updated: 2026-07-24Key Insights
Cardio Diagnostics Holdings Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 202 out of 386 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 60.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cardio Diagnostics Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Cardio Diagnostics Holdings Inc Highlights
StrengthsRisks
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Growing
The company is in a growing phase, with the latest annual income totaling USD 14.82K.
Overvalued
The company’s latest PE is 0.06, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 138.49K shares, decreasing 14.75% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 17.10K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
60.000
Target Price
+1227.43%
Upside Space
Cardio Diagnostics Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
0
analysts
--
Current Rating
60.000
Target Price
+1227.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Cardio Diagnostics Holdings Inc
CDIO
0
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.632
Sell
MA10
1.695
Sell
MA20
1.841
Sell
MA50
1.860
Sell
MA100
2.161
Sell
MA200
2.613
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cardio Diagnostics Holdings Inc Info
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Ticker SymbolCDIO
CompanyCardio Diagnostics Holdings Inc
CEODogan (Meeshanthini V)
Website
Shareholders
Related Instruments
+0.88%
+1.60%
+0.43%
+0.90%
+0.46%
-0.72%
+1.22%
+1.25%
-1.18%
-0.12%
+0.94%
+0.90%
+1.20%
-0.02%
+2.04%
0.00%
+0.63%
-0.69%
+2.59%
+0.89%Popular Instruments
51900.000
+176.000 (+0.34%)
28150.400
-427.600 (-1.50%)
7408.100
-11.800 (-0.16%)
14948.000
-153.000 (-1.01%)
64219.000
-1152.000 (-1.76%)
6264.500
+48.800 (+0.79%)
90.043
-2.069 (-2.25%)
333.020
+11.360 (+3.53%)
206.840
-1.920 (-0.92%)
4052.350
+2.980 (+0.07%)
FAQs
What is the current price of Cardio Diagnostics Holdings Inc (CDIO)?
The current price of Cardio Diagnostics Holdings Inc (CDIO) is 1.55.
What is the symbol of Cardio Diagnostics Holdings Inc?
The ticker symbol of Cardio Diagnostics Holdings Inc is CDIO.
What is the 52-week high of Cardio Diagnostics Holdings Inc?
The 52-week high of Cardio Diagnostics Holdings Inc is 7.91.
What is the 52-week low of Cardio Diagnostics Holdings Inc?
The 52-week low of Cardio Diagnostics Holdings Inc is 0.97.
What is the market capitalization of Cardio Diagnostics Holdings Inc?
The market capitalization of Cardio Diagnostics Holdings Inc is 4.59M.
What is the Earnings Per Share (EPS TTM) of Cardio Diagnostics Holdings Inc (CDIO)?
The Earnings Per Share (EPS TTM) of Cardio Diagnostics Holdings Inc (CDIO) is -3.71.